B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study. (RituxME)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02229942 |
Recruitment Status :
Completed
First Posted : September 3, 2014
Last Update Posted : May 11, 2021
|
Sponsor:
Haukeland University Hospital
Collaborators:
The Research Council of Norway
Norwegian Department of Health and Social Affairs
The Kavli Foundation
Oslo University Hospital
Trondheim University Hospital
University Hospital of North Norway
Sykehuset Telemark
MEandYou Foundation
The Norwegian ME association
Information provided by (Responsible Party):
Haukeland University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | September 2017 |
Actual Study Completion Date : | November 2017 |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):